Savara
SVRA • NASDAQ
Savara is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Pauls, with a market cap of $1.1B.
CEOMatthew Pauls
Next Earnings
Upcoming earnings announcement for Savara
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.14
Earnings History
Past 12 earnings reports for Savara
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Q4 2025 | -$0.13Est: -$0.12 | -8.3% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.14Est: -$0.13 | -7.7% | - | — | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.14Est: -$0.12 | -16.7% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.12Est: -$0.09 | -33.3% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.13Est: -$0.11 | -18.2% | - | — | 10-K/A |
| Nov 12, 2024 | Q3 2024 | -$0.11Est: -$0.11 | 0.0% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.12Est: -$0.11 | -9.1% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.11Est: -$0.10 | -10.0% | - | — | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.09Est: -$0.10 | +10.0% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.10Est: -$0.07 | -42.9% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.07 | — | - | — | — |
| May 15, 2023 | Q1 2023 | -$0.07 | — | - | — | — |